Reversal of Battle-Related Aging (ROBRA) in a Special Operations Forces Cohort

NCT05855876 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-07-17

No results posted yet for this study

Summary

The purpose of this study is to examine measures of GrimAge clock in SOF members undergoing treatment for PTSD/TBI using CSB.

Conditions

Interventions

PROCEDURE

subanesthetic ketamine infusions and bilateral cervical sympathetic blocks

Combined protocol of subanesthetic ketamine infusions and bilateral cervical sympathetic blocks

Sponsors & Collaborators

  • Stella Center

    lead OTHER

Principal Investigators

  • Eugene Lipov, MD · Stella Center

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-05
Primary Completion
2024-04-05
Completion
2024-04-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05855876 on ClinicalTrials.gov